375 related articles for article (PubMed ID: 25555483)
1. Aberrant Cortical Morphometry in the 22q11.2 Deletion Syndrome.
Schmitt JE; Vandekar S; Yi J; Calkins ME; Ruparel K; Roalf DR; Whinna D; Souders MC; Satterwaite TD; Prabhakaran K; McDonald-McGinn DM; Zackai EH; Gur RC; Emanuel BS; Gur RE
Biol Psychiatry; 2015 Jul; 78(2):135-43. PubMed ID: 25555483
[TBL] [Abstract][Full Text] [Related]
2. Cortical Morphology Differences in Subjects at Increased Vulnerability for Developing a Psychotic Disorder: A Comparison between Subjects with Ultra-High Risk and 22q11.2 Deletion Syndrome.
Bakker G; Caan MW; Vingerhoets WA; da Silva-Alves F; de Koning M; Boot E; Nieman DH; de Haan L; Bloemen OJ; Booij J; van Amelsvoort TA
PLoS One; 2016; 11(11):e0159928. PubMed ID: 27828960
[TBL] [Abstract][Full Text] [Related]
3. Structural abnormalities in cortical volume, thickness, and surface area in 22q11.2 microdeletion syndrome: Relationship with psychotic symptoms.
Jalbrzikowski M; Jonas R; Senturk D; Patel A; Chow C; Green MF; Bearden CE
Neuroimage Clin; 2013; 3():405-15. PubMed ID: 24273724
[TBL] [Abstract][Full Text] [Related]
4. Large-scale mapping of cortical alterations in 22q11.2 deletion syndrome: Convergence with idiopathic psychosis and effects of deletion size.
Sun D; Ching CRK; Lin A; Forsyth JK; Kushan L; Vajdi A; Jalbrzikowski M; Hansen L; Villalon-Reina JE; Qu X; Jonas RK; van Amelsvoort T; Bakker G; Kates WR; Antshel KM; Fremont W; Campbell LE; McCabe KL; Daly E; Gudbrandsen M; Murphy CM; Murphy D; Craig M; Vorstman J; Fiksinski A; Koops S; Ruparel K; Roalf DR; Gur RE; Schmitt JE; Simon TJ; Goodrich-Hunsaker NJ; Durdle CA; Bassett AS; Chow EWC; Butcher NJ; Vila-Rodriguez F; Doherty J; Cunningham A; van den Bree MBM; Linden DEJ; Moss H; Owen MJ; Murphy KC; McDonald-McGinn DM; Emanuel B; van Erp TGM; Turner JA; Thompson PM; Bearden CE
Mol Psychiatry; 2020 Aug; 25(8):1822-1834. PubMed ID: 29895892
[TBL] [Abstract][Full Text] [Related]
5. Altered cortical thickness development in 22q11.2 deletion syndrome and association with psychotic symptoms.
Bagautdinova J; Zöller D; Schaer M; Padula MC; Mancini V; Schneider M; Eliez S
Mol Psychiatry; 2021 Dec; 26(12):7671-7678. PubMed ID: 34253864
[TBL] [Abstract][Full Text] [Related]
6. Longitudinal trajectories of cortical thickness as a biomarker for psychosis in individuals with 22q11.2 deletion syndrome.
Ramanathan S; Mattiaccio LM; Coman IL; Botti JC; Fremont W; Faraone SV; Antshel KM; Kates WR
Schizophr Res; 2017 Oct; 188():35-41. PubMed ID: 27988073
[TBL] [Abstract][Full Text] [Related]
7. White matter abnormalities in adults with 22q11 deletion syndrome with and without schizophrenia.
da Silva Alves F; Schmitz N; Bloemen O; van der Meer J; Meijer J; Boot E; Nederveen A; de Haan L; Linszen D; van Amelsvoort T
Schizophr Res; 2011 Oct; 132(1):75-83. PubMed ID: 21831603
[TBL] [Abstract][Full Text] [Related]
8. Deviant trajectories of cortical maturation in 22q11.2 deletion syndrome (22q11DS): a cross-sectional and longitudinal study.
Schaer M; Debbané M; Bach Cuadra M; Ottet MC; Glaser B; Thiran JP; Eliez S
Schizophr Res; 2009 Dec; 115(2-3):182-90. PubMed ID: 19836927
[TBL] [Abstract][Full Text] [Related]
9. Neuroanatomy in adolescents and young adults with 22q11 deletion syndrome: comparison to an IQ-matched group.
Baker K; Chaddock CA; Baldeweg T; Skuse D
Neuroimage; 2011 Mar; 55(2):491-9. PubMed ID: 21184831
[TBL] [Abstract][Full Text] [Related]
10. Cortical morphology development in patients with 22q11.2 deletion syndrome at ultra-high risk of psychosis.
Padula MC; Schaer M; Armando M; Sandini C; Zöller D; Scariati E; Schneider M; Eliez S
Psychol Med; 2018 Oct; 48(14):2375-2383. PubMed ID: 29338796
[TBL] [Abstract][Full Text] [Related]
11. Identifying 22q11.2 deletion syndrome and psychosis using resting-state connectivity patterns.
Scariati E; Schaer M; Richiardi J; Schneider M; Debbané M; Van De Ville D; Eliez S
Brain Topogr; 2014 Nov; 27(6):808-21. PubMed ID: 24562717
[TBL] [Abstract][Full Text] [Related]
12. Longitudinal study of cerebral surface morphology in youth with 22q11.2 deletion syndrome, and association with positive symptoms of psychosis.
Radoeva PD; Bansal R; Antshel KM; Fremont W; Peterson BS; Kates WR
J Child Psychol Psychiatry; 2017 Mar; 58(3):305-314. PubMed ID: 27786353
[TBL] [Abstract][Full Text] [Related]
13. Frontal dysconnectivity in 22q11.2 deletion syndrome: an atlas-based functional connectivity analysis.
Mattiaccio LM; Coman IL; Thompson CA; Fremont WP; Antshel KM; Kates WR
Behav Brain Funct; 2018 Jan; 14(1):2. PubMed ID: 29352808
[TBL] [Abstract][Full Text] [Related]
14. Cortical-amygdala volumetric ratios predict onset of symptoms of psychosis in 22q11.2 deletion syndrome.
Berhanu D; Mattiaccio LM; Antshel KM; Fremont W; Middleton FA; Kates WR
Psychiatry Res Neuroimaging; 2017 Jan; 259():10-15. PubMed ID: 27918911
[TBL] [Abstract][Full Text] [Related]
15. A Comprehensive Analysis of Cerebellar Volumes in the 22q11.2 Deletion Syndrome.
Schmitt JE; DeBevits JJ; Roalf DR; Ruparel K; Gallagher RS; Gur RC; Alexander-Bloch A; Eom TY; Alam S; Steinberg J; Akers W; Khairy K; Crowley TB; Emanuel B; Zakharenko SS; McDonald-McGinn DM; Gur RE
Biol Psychiatry Cogn Neurosci Neuroimaging; 2023 Jan; 8(1):79-90. PubMed ID: 34848384
[TBL] [Abstract][Full Text] [Related]
16. Morphological brain changes associated with negative symptoms in patients with 22q11.2 Deletion Syndrome.
Mihailov A; Padula MC; Scariati E; Schaer M; Schneider M; Eliez S
Schizophr Res; 2017 Oct; 188():52-58. PubMed ID: 28139357
[TBL] [Abstract][Full Text] [Related]
17. Mapping Subcortical Brain Alterations in 22q11.2 Deletion Syndrome: Effects of Deletion Size and Convergence With Idiopathic Neuropsychiatric Illness.
Ching CRK; Gutman BA; Sun D; Villalon Reina J; Ragothaman A; Isaev D; Zavaliangos-Petropulu A; Lin A; Jonas RK; Kushan L; Pacheco-Hansen L; Vajdi A; Forsyth JK; Jalbrzikowski M; Bakker G; van Amelsvoort T; Antshel KM; Fremont W; Kates WR; Campbell LE; McCabe KL; Craig MC; Daly E; Gudbrandsen M; Murphy CM; Murphy DG; Murphy KC; Fiksinski A; Koops S; Vorstman J; Crowley TB; Emanuel BS; Gur RE; McDonald-McGinn DM; Roalf DR; Ruparel K; Schmitt JE; Zackai EH; Durdle CA; Goodrich-Hunsaker NJ; Simon TJ; Bassett AS; Butcher NJ; Chow EWC; Vila-Rodriguez F; Cunningham A; Doherty J; Linden DE; Moss H; Owen MJ; van den Bree M; Crossley NA; Repetto GM; Thompson PM; Bearden CE
Am J Psychiatry; 2020 Jul; 177(7):589-600. PubMed ID: 32046535
[TBL] [Abstract][Full Text] [Related]
18. Prioritizing Genetic Contributors to Cortical Alterations in 22q11.2 Deletion Syndrome Using Imaging Transcriptomics.
Forsyth JK; Mennigen E; Lin A; Sun D; Vajdi A; Kushan-Wells L; Ching CRK; Villalon-Reina JE; Thompson PM; ; Bearden CE
Cereb Cortex; 2021 Jun; 31(7):3285-3298. PubMed ID: 33638978
[TBL] [Abstract][Full Text] [Related]
19. Neural substrates of psychosis revealed by altered dependencies between brain activity and white-matter architecture in individuals with 22q11 deletion syndrome.
Bortolin K; Delavari F; Preti MG; Sandini C; Mancini V; Mullier E; Van De Ville D; Eliez S
Neuroimage Clin; 2022; 35():103075. PubMed ID: 35717884
[TBL] [Abstract][Full Text] [Related]
20. The Psychosis Spectrum in 22q11.2 Deletion Syndrome Is Comparable to That of Nondeleted Youths.
Tang SX; Moore TM; Calkins ME; Yi JJ; Savitt A; Kohler CG; Souders MC; Zackai EH; McDonald-McGinn DM; Emanuel BS; Gur RC; Gur RE
Biol Psychiatry; 2017 Jul; 82(1):17-25. PubMed ID: 27832840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
